Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2023. Start Trial.
Date Value
June 30, 2026 -273.72M
March 31, 2026 -219.93M
December 31, 2025 -245.36M
September 30, 2025 -249.44M
June 30, 2025 -72.94M
March 31, 2025 -212.68M
Date Value
December 31, 2024 -211.17M
September 30, 2024 -206.93M
June 30, 2024 -324.53M
March 31, 2024 -283.94M
December 31, 2023 -248.95M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Personalis, Inc. -100.98M
10X Genomics, Inc. 121.44M
Twist Bioscience Corp. -93.22M
Moderna, Inc. -1.244B
IQVIA Holdings, Inc. 2.184B